The government will allocate the payment to affordable homes programmes across all four nations, including giving funding ...

If accepted, Vifor Pharma's £23m offer will "claw back" money for the NHS and close the CMA's first-ever disparagement case.

All regulatory clearances received for the acquisition of Vifor Pharma AG Settlement of the offer is scheduled for 9 August 2022 Seasoned biopharma executive, Hervé Gisserot, designated to lead ...

Vifor Pharma's shares surged more than 15% in early trading on Monday after the Swiss drugmaker and Australia's CSL both confirmed they were talking about a potential merger.

In a move to diversify its business, Australian biopharma CSL has agreed to acquire Vifor Pharma for $11.7 billion. The deal would give CSL—heavily dependent on vaccines and blood plasma ...

Shares in Vifor Pharma rose sharply after the Swiss drug maker agreed to a $11.7 billion all-cash offer from Australia’s CSL.

Vifor Pharma has offered to launch a marketing campaign to address any damage caused by its criticisms of a rival to its key drug, EU regulators said on Friday, a move that could stave off a ...

Vifor Pharma delivers strong full year results 2020 with an EBITDA of 576 million Swiss Francs representing over 29% growth1 ...

CSL said the regulatory review of its $11.7 billion acquisition of Switzerland’s Vifor Pharma will take “a few more months.” ...

The European Commission has reached a deal with Vifor Pharma after it was accused of disparaging its only rival in the iron deficiency market.

Vifor Pharma has reached deals to acquire Sanifit Therapeutics and Inositec, two companies with clinical-stage drug candidates that address these disease complications.

Vifor Pharma announced today changes to its management. Barbara Angehrn joins the Executive Committee in the newly created position of Chief Business Officer, effective 1 November. Scott Garland ...